Jonathan Lee's Stock Ratings

Guggenheim Analyst

Jonathan Lee is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/14/2024

Overall Average Return

-14.9%

Smart Score

25.5%

Overall Average Return Percentile

15th

Number of Ratings

18
Buy NowGet Alert
05/24/2024ACNBuy Now
Accenture
$286.7137.77% → $395ReiteratesBuy → BuyGet Alert
05/24/2024DAVABuy Now
Endava
$25.45116.11%$60 → $55MaintainsBuyGet Alert
03/19/2024TIXTBuy Now
TELUS Intl
$5.8952.8% → $9Initiates → NeutralGet Alert
03/19/2024DXCBuy Now
DXC Technology
$18.1721.08% → $22Initiates → NeutralGet Alert
03/19/2024CTSHBuy Now
Cognizant Tech Solns
$64.2624.49% → $80Initiates → NeutralGet Alert
03/19/2024TASKBuy Now
TaskUs
$12.910.7% → $13Initiates → NeutralGet Alert
03/19/2024DAVABuy Now
Endava
$25.45135.76% → $60Initiates → BuyGet Alert
03/19/2024EPAMBuy Now
EPAM Sys
$177.5897.09% → $350Initiates → BuyGet Alert
03/19/2024GLOBBuy Now
Globant
$159.3156.93% → $250Initiates → BuyGet Alert
03/19/2024INFYBuy Now
Infosys
$17.7212.87% → $20Initiates → NeutralGet Alert
03/19/2024PRFTBuy Now
Perficient
$74.35-12.58% → $65Initiates → NeutralGet Alert
03/19/2024TTECBuy Now
TTEC Holdings
$6.4224.61% → $8Initiates → SellGet Alert
03/19/2024ACNBuy Now
Accenture
$286.7148.23% → $425Initiates → BuyGet Alert
01/27/2023PRFTBuy Now
Perficient
$74.35-5.85%$75 → $70MaintainsEqual-WeightGet Alert
10/28/2022PTCTBuy Now
PTC Therapeutics
$35.8111.7%$54 → $40MaintainsEqual-WeightGet Alert
10/28/2022PRFTBuy Now
Perficient
$74.350.87%$100 → $75MaintainsEqual-WeightGet Alert
08/08/2022PRFTBuy Now
Perficient
$74.3534.5%$120 → $100MaintainsEqual-WeightGet Alert
04/26/2022PRFTBuy Now
Perficient
$74.3561.4% → $120Initiates → Equal-WeightGet Alert